- Report
- March 2026
- 150 Pages
Canada
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 150 Pages
Germany
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 150 Pages
China
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 150 Pages
India
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 150 Pages
Germany
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 181 Pages
India
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 353 Pages
China
From €4313EUR$4,850USD£3,731GBP
- Report
- March 2026
- 314 Pages
Canada
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 347 Pages
Germany
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 226 Pages
China
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 280 Pages
India
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 334 Pages
Germany
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 185 Pages
Canada
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 239 Pages
China
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 293 Pages
India
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 172 Pages
Canada
From €4313EUR$4,850USD£3,731GBP
- Report
- May 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,731GBP
- Report
- April 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,731GBP
- Report
- April 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,731GBP
- Report
- April 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,731GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more